Drug intelligence / Profile preview

nPT-ery

Development stage
Preclinical
Lead developer
GSK
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

nPT-ery is a program comprising anti-inflammatory erythromycin analogues, developed by Biotica Technology in partnership with GSK. These compounds are macrolide antibiotics specifically engineered to treat inflammatory diseases by leveraging the anti-inflammatory and immunomodulatory actions of erythromycin, which are distinct from its antibacterial activity. The program aims to discover, develop, and commercialize novel erythromycin-based macrolides.

02

Targets

IL-6 (Interleukin 6)IL8 (C-X-C Motif Chemokine Ligand 8)DEL-1 (EGF-like repeat and discoidin I-like domain-containing protein 3 (EDIL3))SELE (E-selectin)GHSR (Growth hormone secretagogue receptor)ICAM1 (Intercellular Adhesion Molecule 1)JAK2 (Janus kinase 2)MAPK14 (p38 mitogen-activated protein kinase alpha)NF-κBSELP (P-selectin)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)VCAM1 (Vascular cell adhesion molecule 1)

Beyond the preview

Go deeper on nPT-ery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nPT-ery.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call